Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Feb 20;5(1):29-33.
doi: 10.1136/svn-2019-000274. eCollection 2020.

Coagulopathy reversal in intracerebral haemorrhage

Affiliations
Review

Coagulopathy reversal in intracerebral haemorrhage

Alexander Jacob Sweidan et al. Stroke Vasc Neurol. .

Abstract

As intracerebral hemorrahge becomes more frequent as a result of an aging population with greater comorbidities, rapid identification and reversal of precipitators becomes increasingly paramount. The aformentioned population will ever more likely be on some form of anticoagulant therapy. Understanding the mechanisms of these agents and means by which to reverse them early on is critical in managing the acute intracerebral hemorrhage.

Keywords: anticoagulation; cerebral hemorrhage; coagulopathy reversal; hemorrhagic stroke.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Algorithm for the reversal of specific anticoagulants, including direct thrombin inhibitors, direct factor Xa inhibitors, warfarin and heparin. FFP, fresh frozen plasma; 4F-PCC, four factor prothrombin complex concentrate;ICH, intracerebral haemorrhage; INR, internationalnormalised ratio; IU, international unit; IV, intravenous; LMWH, low-molecular weight heparin; PCC, prothrombin complex concentrate.

References

    1. Li Q, Zhang G, Xiong X, et al. . Black hole sign: novel imaging marker that predicts hematoma growth in patients with intracerebral hemorrhage. Stroke 2016;47:1777–81. 10.1161/STROKEAHA.116.013186 - DOI - PubMed
    1. Davis SM, Broderick J, Hennerici M, et al. . Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage. Neurology 2006;66:1175–81. 10.1212/01.wnl.0000208408.98482.99 - DOI - PubMed
    1. Butcher KS, Jeerakathil T, Hill M, et al. . The intracerebral hemorrhage acutely decreasing arterial pressure trial. Stroke 2013;44:620–6. 10.1161/STROKEAHA.111.000188 - DOI - PubMed
    1. Feigin VL, Lawes CMM, Bennett DA, et al. . Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. Lancet Neurol 2003;2:43–53. 10.1016/S1474-4422(03)00266-7 - DOI - PubMed
    1. Huttner HB, Schellinger PD, Hartmann M, et al. . Hematoma growth and outcome in treated neurocritical care patients with intracerebral hemorrhage related to oral anticoagulant therapy: comparison of acute treatment strategies using vitamin K, fresh frozen plasma, and prothrombin complex concentrates. Stroke 2006;37:1465–70. 10.1161/01.STR.0000221786.81354.d6 - DOI - PubMed

MeSH terms